Supplementary Figure 2 from Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma
Year: 2023
Type: supplementary-materials
Abstract: PDF file, 71KB, Bevacizumab does not alter in vitro LPAM chemosensitivity.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361819165